Table 2.

Clinical characteristics of patients, S100A7 expression and the survival analysis

	S100A7 experssion			Log rank	Median	Log rank	Cox regression
Factors	+ (n)	- (n)	P	Total	Survival(Months)	Subgroup	Univariate			Multivariate
				P		P	HR	95% CI	P	HR	95% CI	P
Gender			0.304	0.274
Femal (n=38)	14	24			57.12	0.075
Male (n=105)	63	42			59.20	0.024
Age			0.29	0.451
< 60 y (n=49)	30	19			59.13	0.146
≥ 60 y (n=94)	57	37			52.24	0.018
Tumor size			0.014	0.000
T1+T2 (n=92)	71	21			62.3	0.0026	2.128	1.38-3.472	0.002	1.563	1.028-2.859	0.047
T3+T4 (n=51)	16	35			36.2	0.437
Differentiation			0.473	0.269
Low (n=94)	62	32			52.8	0.016
Moderate/high (n=49)	25	24			60.5	0.162
Lymph node			0.063	0.000			2.846	1.93-5.053	0.001	2.73	1.40-3.180	0.02
N0+N1 (n=106)	69	37			61.5	0.012
N2+N3 (n=37)	18	19			30.8	0.165
Distant M			0.258	0.684			1.235	0.63-2.158	0.392
M0 (n=131)	79	52			59.6	0.006
M1 (n=12)	8	4			44.8	0.538
Clinical stage			0.082	0.0013			2.35	1.364-3.86	0.001	0.93	0.435-1.132	0.876
I+II (n=89)	49	40			615	0.038
III+IV (n=54)	38	16			37.9	0.026
S100A7 (n=143)	87	56	0.001	0.007	58.2/43.8		1.926	1.23-3.28	0004.	2.01	1.35-4.157	0.002